|drug1545||Laboratory Analyses Wiki||1.00|
|drug3139||Xiyanping injection Wiki||1.00|
|D018352||Coronavirus Infections NIH||0.04|
There is one clinical trial.
the investigators conduct a randomized, open-label trial to evaluate and compare the safety and efficacy of Xiyanping injection in patients with 2019-nCoV pneumonia.
Description: From the beginning of study drug use to fever, respiratory rate, blood oxygen saturation to normal and cough relief, and maintained for at least 72 hours or more, calculated in hoursMeasure: Clinical recovery time Time: Up to Day 14
Description: From the beginning of research drug use to body temperature <37.3 ℃ (underarm) or mouth temperature ≤37.5 ° C, or anal or ear temperature ≤37.8 ° C, and maintained for 24h or moreMeasure: Complete fever time Time: Up to Day 14
Description: Cough score "day + night" from the beginning of study medication to cough ≤ 1 point, and maintained for 24 hours and aboveMeasure: Cough relief time Time: Up to Day 14
Description: From the beginning of the study drug to two consecutive times (sampling interval of at least 1 day)Measure: Virus negative time Time: Up to Day 14
Description: Defined as the proportion of subjects exacerbated during treatment and meeting the diagnostic criteria for severe or critical neocoronavirus pneumoniaMeasure: Incidence of severe or critical neocoronavirus pneumonia Time: Up to Day 14